BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Takeishi K, Maeda T, Shirabe K, Tsujita E, Yamashita Y, Harimoto N, Itoh S, Ikegami T, Yoshizumi T, Maehara Y. Clinicopathologic Features and Outcomes of Non-B, Non-C Hepatocellular Carcinoma After Hepatectomy. Ann Surg Oncol 2015;22 Suppl 3:S1116-24. [PMID: 26159442 DOI: 10.1245/s10434-015-4728-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Hashimoto M, Tashiro H, Kobayashi T, Kuroda S, Hamaoka M, Ohdan H. Clinical characteristics and prognosis of non-B, non-C hepatocellular carcinoma: The impact of patient sex on disease-free survival - A retrospective cohort study. Int J Surg 2017;39:206-13. [PMID: 28159713 DOI: 10.1016/j.ijsu.2017.01.110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Liao M, Sun J, Zhang Q, Tang C, Zhou Y, Cao M, Chen T, Hu C, Yu J, Song Y, Li M, Liao W, Zhou Y. A Novel Post-Operative ALRI Model Accurately Predicts Clinical Outcomes of Resected Hepatocellular Carcinoma Patients. Front Oncol 2021;11:665497. [PMID: 34295811 DOI: 10.3389/fonc.2021.665497] [Reference Citation Analysis]
3 Tan Y, Xie XY, Li XJ, Liu DH, Zhou LY, Zhang XE, Lin Y, Wang W, Wu SS, Liu J, Huang GL. Comparison of hepatic epithelioid angiomyolipoma and non-hepatitis B, non-hepatitis C hepatocellular carcinoma on contrast-enhanced ultrasound. Diagn Interv Imaging 2020;101:733-8. [PMID: 32331793 DOI: 10.1016/j.diii.2020.03.005] [Reference Citation Analysis]
4 Takeishi K, Yoshizumi T, Itoh S, Yugawa K, Yoshiya S, Toshima T, Harada N, Ikegami T, Nishie A, Mori M. Surgical Indications for Hepatocellular Carcinoma with Non-hypervascular Hypointense Nodules Detected by Gd-EOB-DTPA-Enhanced MRI. Ann Surg Oncol 2020;27:3344-53. [PMID: 32246316 DOI: 10.1245/s10434-020-08419-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hsu PY, Hsu CT, Yeh ML, Huang CF, Huang CI, Liang PC, Lin YH, Hsieh MY, Wei YJ, Hsieh MH, Dai CY, Lin ZY, Chen SC, Huang JF, Yu ML, Chuang WL. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C. Dig Dis Sci 2020;65:2120-9. [PMID: 31722058 DOI: 10.1007/s10620-019-05938-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Itoh S, Yoshizumi T, Tomino T, Nagatsu A, Motomura T, Harada N, Harimoto N, Ikegami T, Soejima Y, Maehara Y. Associations between antibody to hepatitis B core antigen positivity and outcomes in hepatocellular carcinoma patients undergoing hepatic resection: Associations of HBcAb in HCC. Hepatol Res 2018;48:E155-61. [DOI: 10.1111/hepr.12939] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Mulder RL, Bresters D, Van den Hof M, Koot BG, Castellino SM, Loke YKK, Post PN, Postma A, Szőnyi LP, Levitt GA, Bardi E, Skinner R, van Dalen EC. Hepatic late adverse effects after antineoplastic treatment for childhood cancer. Cochrane Database Syst Rev 2019;4:CD008205. [PMID: 30985922 DOI: 10.1002/14651858.CD008205.pub3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
8 Wang J, Shan Q, Liu Y, Yang H, Kuang S, He B, Zhang Y, Chen J, Zhang T, Glaser KJ, Zhu C, Chen J, Yin M, Venkatesh SK, Ehman RL. 3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence. J Magn Reson Imaging 2019;49:719-30. [PMID: 30260529 DOI: 10.1002/jmri.26250] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]